Relative risk ratio | 95% Confidence Interval | p-value | |
---|---|---|---|
Age | |||
≤ 30 | Ref. | ||
41–50 | 1.04 | 0.20–5.32 | 0.964 |
51–60 | 0.84 | 0.17–4.18 | 0.834 |
61–70 | 1.28 | 0.25–6.49 | 0.766 |
71–80 | 1.19 | 0.25–5.68 | 0.831 |
81–90 | 2.24 | 0.46–10.9 | 0.318 |
Gender | |||
male | Ref. | ||
female | 0.86 | 0.62–1.18 | 0.346 |
Race | |||
White | Ref. | ||
Black | 0.36 | 0.11–1.14 | 0.081 |
Other/unknown | 1.97 | 0.71–5.46 | 0.193 |
Year of Diagnosis | |||
2011 | Ref. | ||
2012 | 1.28 | 0.82–2.01 | 0.287 |
2013 | 1.08 | 0.69–1.70 | 0.728 |
2014 | 1.40 | 0.89–2.22 | 0.147 |
2015 | 1.83 | 1.17–2.87 | 0.008 |
Charlson Deyo Index | |||
0 | Ref. | ||
1 | 1.11 | 0.73–1.71 | 0.623 |
2 | 1.30 | 0.50–2.21 | 0.888 |
> =3 | 1.93 | 0.77–4.87 | 0.162 |
Primary Site | |||
Head and Neck | Ref. | ||
trunk | 1.41 | 0.74–2.71 | 0.294 |
extremities | 1.30 | 0.72–2.33 | 0.379 |
overlapping | 1.25 | 0.60–2.63 | 0.550 |
Histology | |||
Melanoma, NOS | Ref. | ||
nodular | 0.78 | 0.44–1.39 | 0.396 |
Lentigo | 0.35 | 0.04–3.44 | 0.369 |
superficial | 0.87 | 0.38–2.00 | 0.749 |
Acral | 0.47 | 0.07–3.01 | 0.424 |
other | 0.91 | 0.43–1.93 | 0.798 |
Metastatic stage | |||
M1, NOS | Ref. | ||
M1a | 0.42 | 0.15–1.17 | 0.097 |
M1b, lung | 0.39 | 0.14–1.10 | 0.075 |
M1c, visceral | 0.22 | 0.08–0.62 | 0.004 |
Brain involvement | 0.44 | 0.15–1.23 | 0.116 |
Ulceration | |||
No ulceration | Ref. | ||
ulceration | 0.88 | 0.54–1.46 | 0.631 |
unknown | 0.63 | 0.35–1.15 | 0.132 |
Breslow (continuous) | 1.00 | 1.00–1.00 | 0.141 |
Insurance | |||
Private | Ref. | ||
Medicare | 1.13 | 0.74–1.71 | 0.576 |
Medicaid | 2.10 | 1.12–3.92 | 0.020 |
Other | 1.11 | 0.34–3.63 | 0.850 |
No insurance | 2.44 | 1.28–4.67 | 0.007 |
unknown | 0.28 | 0.07–1.16 | 0.080 |
Income* | |||
≥ $63,000 | Ref. | ||
$48,999–$62,999 | 1.25 | 0.65–2.40 | 0.509 |
$38,000–$47,999 | 0.93 | 0.36–2.41 | 0.887 |
< $38,000 | 1.71 | 0.57–5.14 | 0.339 |
unknown | 0.29 | 0.02–3.54 | 0.333 |
Education*,** | |||
≥ 21% | Ref. | ||
13%-20,9% | 1.14 | 0.55–2.37 | 0.730 |
7–12,9% | 0.97 | 0.40–2.33 | 0.943 |
< 7% | 0.61 | 0.21–1.76 | 0.360 |
unknown | 6.10 | 0.38–98.55 | 0.203 |
Distance | |||
< 12.5mi | Ref. | ||
12.5-50mi | 0.58 | 0.38–0.88 | 0.011 |
≥ 50mi | 0.14 | 0.07–0.30 | < 0.001 |
unknown | 0.38 | 0.07–2.23 | 0.285 |
Facility Location | |||
Northeast | Ref. | ||
South | 5.06 | 0.98–26.03 | 0.052 |
Midwest | 0.97 | 0.15–6.06 | 0.973 |
West | 1.81 | 0.35–9.30 | 0.475 |
Facilitytype | |||
Academic | Ref. | ||
CCCP | 5.18 | 1.69–15.88 | 0.004 |
INCP | 6.60 | 1.06–41.14 | 0.043 |
County | |||
Metro | Ref. | ||
Urban | 2.58 | 1.34–4.96 | 0.005 |
Rural | 1.93 | 0.32–11.74 | 0.476 |
unknown | 1.25 | 0.45–3.45 | 0.671 |
Abbreviations: NOS = not otherwise specified, mi = miles; CCCP = comprehensive community cancer program; INCP = integrated network cancer program
Significant p-values in italic
*ZIP-code level variable
**Percentage of residents in home county with no high school degree from 2012 American County Survey Data